to improve your browsing experience . for further information including how to withdraw consent please refer to our cookie policy . by clicking accept below or continuing to use this website including closing this message you confirm that you have read and consent to our use of cookies as detailed in our cookie policy . accept close top of this page skip navigation go straight to the content mobile menu search ucb inspired by patients . driven by science . home our company overview vision strategy history management facts and figures company financials pipeline csr csr csr ucb governance performance & reporting patient environment ucb societal responsibility fund animal research in the uk animal research in belgium animals used for research in 2015 transparency finland sweden belgium hungary italy the netherlands ukraine ireland denmark norway romania ucb stories our products overview product list immunology cimzia ankylosing spondylitis cimzia axial spondyloarthritis cimzia crohn s disease cimzia psoriatic arthritis cimzia rheumatoid arthritis xyzal zyrtec lortab tussionex neurology briviact vimpat neupro keppra metadate cd nootropil xyrem r & d overview pipeline info centre drug development process how drugs are named nce & nbe drug discovery overview facts & figures ucb periodic table ucb s definition of severe diseases data transparency clinical study information tech access overview antibody programme our antibody technology additional capabilities applying to the antibody programme faq s ucb stories partnering overview partnering areas of interest our partnering process news and articles contact ucb stories funding overview usa donations grants investigator initiated studies sponsorships other countries donation grants investigator initiated studies sponsorships ucb stories stories in focus patients overview conditions immunology allergies ankylosing spondylitis crohn s disease juvenile rheumatoid arthritis psoriatic arthritis respiratory disorders rheumatoid arthritis systemic lupus sle osteoporosis neurology epilepsy adhd memory problems narcolepsy parkinson s disease restless legs syndrome rls family planning and pregnancy initiative testimonials crohn s disease barbara carrie craig miranda ally epilepsy alexander beatriz catherine jerome lloyd lupus aurore mary nuria sander wendy parkinson s disease allen alun carlos christer jesus sheila veronica rheumatoid arthritis alison alice peterson clinical trials about clinical trials faq phase i phase ii phase iii phase iv ucb policy trial information search trial results search patient programmes support of patient organisations in europe 2015 2014 2013 2012 canine assistants programme ucb stories my rls monitor parkinson s well being map uk cz hu mx nl es si ro gr us at fr dk se fi healthcare professionals overview immunology if joints could speak new evolutions on joint imaging towards personalised treatment mri for axial spa not always black and white welcome ucb sponsored data spondyloarthritis symposium ra symposium neurology when and how to start adjunctive therapy ; learning from clinical trials and real world data 18th annual international clinical symposium kempenhaeghe personalised antiepileptic drug treatment cognitive and quality of life outcomes in epilepsy presurgical evaluation and epilepsy surgery cognitive decline in adult epilepsy brain on a chip a model for brain disease assessment and treatment of gastrointestinal dysfunction in parkinson s disease accelerated cognitive ageing in adult epilepsy is neurostimulation a potential cognitive modulator in epilepsy planning for a family concerns and questions from a person living with epilepsy parkinson s disease latest findings on therapeutic effectiveness practical reflections on the actual treatment of parkinson s disease iec 2015 cognitive vulnerability in patients with epilepsy consequences of disease and treatment epilepsy in the older adult current management and treatment trends choice of technology to improve outcomes in epilepsy surgery ean 2015 enzyme induction with antiepileptic drugs practical considerations for treatment decisions in new or recently diagnosed epilepsy patients monitoring cognitive side effects of antiepileptic drugs aed approaching the individual patient key learnings from a prospective real life study with lacosamide vitoba epilepsy in the elderly treatment challenges and possible solutions ucb patient experience workshop epilepsy as a co morbidity in the hospitalized patient management of epilepsy in patients with brain tumors assessment of cognition in epilepsy therapy therapy of patients with epilepsy and intellectual disabilities early combination therapy benefits of early treatment initiation in parkinson s disease continuous dopaminergic therapy implications of non oral therapy investors overview ucb in brief ucb today cimzia vimpat neupro keppra ucb tomorrow pipeline brivaracetam romosozumab financials key figures full year overview half year overview annual reports annual reports 2005 2009 annual reports 2000 2004 interim reports financials 2013 financials 2012 financials 2011 financials 2010 financials 2009 financials 2008 financials 2007 financial reports fr financial reports nl bonds emtn institutional eurobond 2009 institutional eurobond 2013 institutional eurobond 2015 perpetual bond retail bond 2009 retail bond 2013 retail bond public exchange offer emtn notes share info governance shareholders information shareholders meeting shareholders meeting 2014 shareholders meeting 2013 shareholders meeting 2012 shareholders meeting 2011 shareholders meeting 2010 shareholders meeting 2009 shareholders meeting 2008 corporate governance principles codes and guidelines governance reports corporate governance statements fr corporate governance statements nl news ucb stories contact media overview news resources press contact suppliers overview suppliers australia austria belgium brazil bulgaria canada china czech republic denmark finland france germany greece hong kong hungary japan india ireland italy korea luxembourg malaysia mexico netherlands norway poland portugal romania russia singapore slovakia spain sweden switzerland taiwan thailand turkey uk usa sourcing bidding einvoicing careers overview our company our values your career leadership and personal development compensation and company benefits striking the right work life balance traineeships applying to ucb agilytical analyvative attentification carentific carountable collaboronable collabovative comforganized concluencer creativodological curioupreneur curioneering curiolistic curiousistent entreprecurious drivethusiastic drivenovative empathezed empalytic empaneering empatherative empathriven energanized pioneeriastic ethiborative futurytical helpfulurist helpfuturist holiborative honestegic innopreneur innoborative innovagrity innogrity innolytic integrivative reliavative inspilytical inspirific scieninspiring logiborative methotivity negoborative networkogical inspartnering propartnering passionative passiovative passiodological patienthetic pioneerious pioneesiastic pragmathetic predictpreneur purpossionate strational scienassionate stragile stratelytical analytegic strategiven synthelytical trustganizeducb worldwide patients overview conditions immunology allergies ankylosing spondylitis crohn s disease juvenile rheumatoid arthritis psoriatic arthritis respiratory disorders rheumatoid arthritis systemic lupus sle osteoporosis neurology epilepsy adhd memory problems narcolepsy parkinson s disease restless legs syndrome rls family planning and pregnancy initiative testimonials crohn s disease barbara carrie craig miranda ally epilepsy alexander beatriz catherine jerome lloyd lupus aurore mary nuria sander wendy parkinson s disease allen alun carlos christer jesus sheila veronica rheumatoid arthritis alison alice peterson clinical trials about clinical trials faq phase i phase ii phase iii phase iv ucb policy trial information search trial results search patient programmes support of patient organisations in europe 2015 2014 2013 2012 canine assistants programme ucb stories my rls monitor parkinson s well being map uk cz hu mx nl es si ro gr us at fr dk se fi healthcare professionals overview immunology if joints could speak new evolutions on joint imaging towards personalised treatment mri for axial spa not always black and white welcome ucb sponsored data spondyloarthritis symposium ra symposium neurology when and how to start adjunctive therapy ; learning from clinical trials and real world data 18th annual international clinical symposium kempenhaeghe personalised antiepileptic drug treatment cognitive and quality of life outcomes in epilepsy presurgical evaluation and epilepsy surgery cognitive decline in adult epilepsy assessment and treatment of gastrointestinal dysfunction in parkinson s disease brain on a chip a model for brain disease accelerated cognitive ageing in adult epilepsy is neurostimulation a potential cognitive modulator in epilepsy planning for a family concerns and questions from a person living with epilepsy parkinson s disease latest findings on therapeutic effectiveness practical reflections on the actual treatment of parkinson s disease iec 2015 cognitive vulnerability in patients with epilepsy consequences of disease and treatment epilepsy in the older adult current management and treatment trends choice of technology to improve outcomes in epilepsy surgery ean 2015 enzyme induction with antiepileptic drugs practical considerations for treatment decisions in new or recently diagnosed epilepsy patients monitoring cognitive side effects of antiepileptic drugs aed approaching the individual patient key learnings from a prospective real life study with lacosamide vitoba epilepsy in the elderly treatment challenges and possible solutions ucb patient experience workshop epilepsy as a co morbidity in the hospitalized patient management of epilepsy in patients with brain tumors assessment of cognition in epilepsy therapy therapy of patients with epilepsy and intellectual disabilities early combination therapy benefits of early treatment initiation in parkinson s disease continuous dopaminergic therapy implications of non oral therapy investors overview ucb in brief ucb today cimzia vimpat neupro keppra ucb tomorrow pipeline brivaracetam romosozumab financials key figures full year overview half year overview annual reports annual reports 2005 2009 annual reports 2000 2004 interim reports financials 2013 financials 2012 financials 2011 financials 2010 financials 2009 financials 2008 financials 2007 financial reports fr financial reports nl bonds emtn institutional eurobond 2009 institutional eurobond 2013 institutional eurobond 2015 perpetual bond retail bond 2009 retail bond 2013 retail bond public exchange offer emtn notes share info governance shareholders information shareholders meeting shareholders meeting 2014 shareholders meeting 2013 shareholders meeting 2012 shareholders meeting 2011 shareholders meeting 2010 shareholders meeting 2009 shareholders meeting 2008 corporate governance principles codes and guidelines governance reports corporate governance statements fr corporate governance statements nl news ucb stories contact media overview news resources press contact suppliers overview suppliers australia austria belgium brazil bulgaria canada china czech republic denmark finland france germany greece hong kong hungary japan india ireland italy korea luxembourg malaysia mexico netherlands norway poland portugal romania russia singapore slovakia spain sweden switzerland taiwan thailand turkey uk usa sourcing bidding einvoicing careers overview our company our values your career leadership and personal development compensation and company benefits striking the right work life balance traineeships applying to ucb agilytical analyvative attentification carentific carountable collaboronable collabovative comforganized concluencer creativodological curioupreneur curioneering curiolistic curiousistent entreprecurious drivethusiastic drivenovative empathezed empalytic empaneering empatherative empathriven energanized pioneeriastic ethiborative futurytical helpfulurist helpfuturist holiborative honestegic innopreneur innoborative innovagrity innogrity innolytic integrivative reliavative inspilytical inspirific scieninspiring logiborative methotivity negoborative networkogical inspartnering propartnering passionative passiovative passiodological patienthetic pioneerious pioneesiastic pragmathetic predictpreneur purpossionate strational scienassionate stragile stratelytical analytegic strategiven synthelytical trustganized ucb stories more than medicines at ucb we are working to develop and deliver medicines that improve quality of life for people with severe diseases . but our ... innovative wellness program for rheumatoid arthritis people with rheumatoid arthritis ra are at higher risk for cardiovascular and ... view all articles ucb on youtube celebrating scientific excellence ucb s core antibody discovery facidui te tem ip ea consed estinin in focus welcome to the quiz on osteoporosis test your knowledge on osteoporosis and challenge a friend latest news 07 oct 16 transparency notification 02 oct 16 cimzia certolizumab pegol phase 3 trial meets co primary efficacy endpoints in patients with moderate to severe chronic plaque psoriasis 26 sep 16 ucb and amgen announce u.s. fda acceptance of biologics licence application for romosozumab view all press releases ucb worldwide find a locationselect countryaustralia & new zealandaustriabelgium & luxembourgbrazilbulgariacanadachinaczech republicdenmarkegyptfinlandfrancegermanygreecehungaryindiairelanditalyjapankazachstankoreamexico & latin americanorwaypolandportugalromaniarussia cis slovak republicspainswedenswitzerlandthe netherlandsturkeyukraineunited kingdomu.s.a . careers at ucb explore ucb s career options access our careers portalaccess our careers portal investor relations explore ucb s investor relations sectionselect a topicshare price informationlatest reportsconsensuslatest presentationshareholders structureagm infocontact 2007 2016 ucb s.a. belgium . all rights reserved legal notice privacy policy cookie policy contact print site map last updated on september 12 2016 search submit facebook rss feed linkedin youtube twitter